Black residents living in highly segregated neighborhoods have significantly shortened life expectancies, reports a new Northwestern Medicine study.
MASH revival with over $2.5bn for innovator drug partnership deals in 2024 – Pharmaceutical Technology
Share this article Source: GlobalData, Pharma Intelligence Center, Deals Database* (Accessed 20 March 2024) ©GlobalData. Metabolic dysfunction-associated steatohepatitis (MASH) innovator drugs witnessed an over $2.5bn